Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS3 | P17931 | 10/20 | 0.58 |
| ▸ | LGALS9 | O00182 | 8/20 | 0.58 |
| ▸ | LGALS1 | P09382 | 8/20 | 0.58 |
| ▸ | LGALS7; LGALS7B | P47929 | 7/20 | 0.58 |
| ▸ | LGALS8 | O00214 | 5/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.38 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14878341 | 1.00 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL14546394 | 1.00 | LGALS3 (0.58) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL13804416 | 0.92 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL13814628 | 0.92 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL14878331 | 0.92 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL14900285 | 0.92 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL13804400 | 0.92 | LGALS3 (0.61) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL15086139 | 0.92 | LGALS3 (0.47) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL14878337 | 0.84 | LGALS9 (0.41) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 | |
| SCHEMBL15086161 | 0.84 | LGALS3 (0.50) | LGALS3LGALS9LGALS1LGALS7; LGALS7BLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9709571-B2 | Method of drug design | VAST BIOSCIENCE PTY LIMITED (AU) | 2017-07-18 | — | — | US | disclosed |
| US-20130172210-A1 | METHOD OF DRUG DESIGN | ALCHEMIA LIMITED (AU) | 2013-07-04 | — | — | US | disclosed |
| US-8222381-B2 | Derivatives of monosaccharides for drug discovery | ALCHEMIA LIMITED (AU) | 2012-07-17 | — | — | US | disclosed |
| US-7737287-B2 | Anomeric derivatives of monosaccharides | ALCHEMIA LIMITED (AU) | 2010-06-15 | — | — | US | disclosed |